Physician profile
Vikram Shah
NPI 1326013079
$7,765.69
in general payments reported to CMS, 2019-2025
27 companies · $4,250 in 2025
The $4,250 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $422 · 2021: $450 · 2022: $621 · 2023: $867 · 2024: $734 · 2025: $4,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $2,271 · Travel and Lodging: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $2,270.59 |
| Travel and Lodging | $1,080.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,804.46 | 2025 | |
| Glaxosmithkline, LLC. | $1,767.04 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Olympus Corporation of The Americas | $808.23 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $330.16 | 2020-2023 | Glassia |
| Fujifilm Healthcare Americas Corporation | $270.52 | 2024 | Fujifilm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $259.50 | 2019-2025 | Ofev |
| Astrazeneca Pharmaceuticals Lp | $196.59 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Genentech USA, INC. | $193.28 | 2019-2023 | Xolair |
| Inspire Medical Systems, INC. | $179.47 | 2023-2024 | Inspire |
| Pulmonx Corporation | $144.33 | 2023-2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Insmed, INC. | $143.73 | 2020-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $106.45 | 2020-2024 | |
| Grifols USA, LLC | $104.91 | 2022-2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $97.80 | 2020-2024 | Wakix |
| Jazz Pharmaceuticals INC. | $53.01 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $44.69 | 2022-2024 | Xarelto |
| Inogen, INC. | $43.13 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Mylan Specialty L.P. | $37.89 | 2021-2024 | Yupelri |
| Circassia INC. | $36.79 | 2019-2020 | |
| Viatris Specialty LLC | $29.46 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $20.48 | 2022 | |
| Amgen INC. | $19.79 | 2024 | Tezspire |
| Merck Sharp & Dohme LLC | $16.77 | 2023 | |
| Verona Pharma, INC. | $16.01 | 2025 | Ohtuvayre |
| Mallinckrodt Hospital Products INC. | $15.93 | 2021 | |
| Tactile Systems Technology INC | $13.07 | 2023 | Entre Plus, Flexitouch Plus |
| Nuwellis, INC. | $12.20 | 2023 | Aquadex Smartflow Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.